At Future Fabrics Expo in London, the company showcased samples that it says are “structurally and genetically identical to traditional leather”.

The product uses only immortalised cells – isolated and collected from an adult female horse following a strict and painless bioethics process – to produce a skin/hide structure in a lab over six weeks without the use of any additional supporting materials such as plastics or cellulose in the final skin product.

3DBT says that lab-grown leather’s advantages over traditional, “farm-based” leather are that it skips steps like fleshing and dehairing, while inconsistencies and imperfections in hides and skins can be avoided.

The project was undertaken with the University of Northampton and funded by the UK Research and Innovation (UKRI) through Innovate UK with the support of co-funders including the Scottish Funding Council, Welsh Government, Invest Northern Ireland and the Department of Department for Business, Energy and Industrial Strategy (BEIS).

Professor Will Wise, from the University of Northampton, said: “This project has far-reaching scope, it will allow us to understand more about the fundamentals of collagen modification as well as developing a new biomaterial for commercial use. It is fantastic to be a part of it, and to work in close partnership with 3DBT to achieve their goals.”

3DBT Senior Research and Development Scientist Dr Emily Telford added: “We are really excited to be working with the University of Northampton to merge our innovative bioengineered skin with their vast knowledge of traditional leather processing techniques. We believe this initiative will address the growing demand for both conventional and alternative leathers as we strive for a more sustainable future.”